Do you have the same question? Follow this Question
Sep 18, 2024 - 12:42 PM
We’ve provided several answers to questions related to Trelegy Ellipta (Fluticasone Furoate / Umeclidinium / Vilanterol Trifenatate) , see some other helpful Q&A related to this product.
Question: Is Trelegy a high-risk medication?
Answer: Trelegy Ellipta is not considered a high-risk medication, but it does have potential side effects. Always consult your doctor for personalized advice to ensure it’s safe for your specific health conditions.
Question: Can Trelegy Ellipta be used for acute bronchospasm or asthma treatment?
Answer: No, Trelegy Ellipta should not be used for acute bronchospasm or asthma treatment. For immediate relief, a rescue inhaler like albuterol should be used. Trelegy is meant for chronic, long-term management.
Question: What is fluticasone fumarate?
Answer: Fluticasone fumarate is an inhaled corticosteroid (ICS) that reduces inflammation in the lungs, making it easier to breathe for COPD patients. Reducing inflammation is vital for improving airflow and respiratory function.
Question: What is the DrugBank ID for Trelegy Ellipta?
Answer: The DrugBank IDs for Trelegy Ellipta are DB08906, DB09076, and DB09082. These IDs are used in databases to provide detailed information about the drug.
Question: What is the dosage strength of Trelegy Ellipta?
Answer: Trelegy Ellipta comes in dosages of 92/55/22mcg (100/62.5/25mcg) and 200/62.5/25mcg, with each inhaler containing 30 doses. Dosage strength is crucial for ensuring the medication is effective for individual patient needs.
View all Trelegy Ellipta (Fluticasone Furoate / Umeclidinium / Vilanterol Trifenatate) Questions & Answers
